Published in Healthcare Finance, Tax and Law Weekly, February 14th, 2007
Fourth quarter 2006 sales increased 39% over third quarter 2006. Unaudited sales for the full year 2006 increased 78.67% to US$15.41 million, compared to audited sales of US$8.6 million for the full year 2005.
The sales growth in the fourth quarter of 2006 was primarily attributable to increased sales of Healive, Sinovac's inactivated hepatitis A vaccine. Sinovac believes that the domestic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.